These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 25762022)

  • 1. Bioreactor process parameter screening utilizing a Plackett-Burman design for a model monoclonal antibody.
    Agarabi CD; Schiel JE; Lute SC; Chavez BK; Boyne MT; Brorson KA; Khan M; Read EK
    J Pharm Sci; 2015 Jun; 104(6):1919-1928. PubMed ID: 25762022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the linkage between cell culture process parameters and downstream processing utilizing a plackett-burman design for a model monoclonal antibody.
    Agarabi CD; Chavez BK; Lute SC; Read EK; Rogstad S; Awotwe-Otoo D; Brown MR; Boyne MT; Brorson KA
    Biotechnol Prog; 2017 Jan; 33(1):163-170. PubMed ID: 27813291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparisons of the glycosylation of a monoclonal antibody produced under nominally identical cell culture conditions in two different bioreactors.
    Kunkel JP; Jan DC; Butler M; Jamieson JC
    Biotechnol Prog; 2000; 16(3):462-70. PubMed ID: 10835250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fermentanomics: Relating quality attributes of a monoclonal antibody to cell culture process variables and raw materials using multivariate data analysis.
    Rathore AS; Kumar Singh S; Pathak M; Read EK; Brorson KA; Agarabi CD; Khan M
    Biotechnol Prog; 2015; 31(6):1586-99. PubMed ID: 26280800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of manipulated variables for a glycosylation control strategy.
    St Amand MM; Radhakrishnan D; Robinson AS; Ogunnaike BA
    Biotechnol Bioeng; 2014 Oct; 111(10):1957-70. PubMed ID: 24728980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production and molecular characterization of clinical phase i anti-melanoma mouse IgG3 monoclonal antibody R24.
    Kemminer SE; Conradt HS; Nimtz M; Sagi D; Peter-Katalinić J; Diekmann O; Drmić I; Müthing J
    Biotechnol Prog; 2001; 17(5):809-21. PubMed ID: 11587568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying a robust design space for glycosylation during monoclonal antibody production.
    St Amand MM; Hayes J; Radhakrishnan D; Fernandez J; Meyer B; Robinson AS; Ogunnaike BA
    Biotechnol Prog; 2016 Sep; 32(5):1149-1162. PubMed ID: 27273898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the impact of cell culture process parameters on monoclonal antibody N-glycosylation.
    Ivarsson M; Villiger TK; Morbidelli M; Soos M
    J Biotechnol; 2014 Oct; 188():88-96. PubMed ID: 25173615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation and modeling of monoclonal antibody N-linked glycosylation in mammalian cell perfusion reactors.
    Karst DJ; Scibona E; Serra E; Bielser JM; Souquet J; Stettler M; Broly H; Soos M; Morbidelli M; Villiger TK
    Biotechnol Bioeng; 2017 Sep; 114(9):1978-1990. PubMed ID: 28409838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of cell culture process parameters for modulating mAb afucosylation.
    Nguyen Dang A; Mun M; Rose CM; Ahyow P; Meier A; Sandoval W; Yuk IH
    Biotechnol Bioeng; 2019 Apr; 116(4):831-845. PubMed ID: 30597531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneous conditions in dissolved oxygen affect N-glycosylation but not productivity of a monoclonal antibody in hybridoma cultures.
    Serrato JA; Palomares LA; Meneses-Acosta A; Ramírez OT
    Biotechnol Bioeng; 2004 Oct; 88(2):176-88. PubMed ID: 15449295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Designed Amino Acid Feed in Improvement of Production and Quality Targets of a Therapeutic Monoclonal Antibody.
    Torkashvand F; Vaziri B; Maleknia S; Heydari A; Vossoughi M; Davami F; Mahboudi F
    PLoS One; 2015; 10(10):e0140597. PubMed ID: 26480023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissolved oxygen concentration in serum-free continuous culture affects N-linked glycosylation of a monoclonal antibody.
    Kunkel JP; Jan DC; Jamieson JC; Butler M
    J Biotechnol; 1998 Jun; 62(1):55-71. PubMed ID: 9684342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of a Plackett-Burman statistical design to determine the effect of selected amino acids on monoclonal antibody production in CHO cells.
    González-Leal IJ; Carrillo-Cocom LM; Ramírez-Medrano A; López-Pacheco F; Bulnes-Abundis D; Webb-Vargas Y; Alvarez MM
    Biotechnol Prog; 2011; 27(6):1709-17. PubMed ID: 21901863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and Analytics of a Monoclonal Antibody from Chinese Hamster Ovary Cells Using an Automated Microbioreactor System.
    Velugula-Yellela SR; Powers DN; Angart P; Faustino A; Faison T; Kohnhorst C; Fratz-Berilla EJ; Agarabi CD
    J Vis Exp; 2019 May; (147):. PubMed ID: 31107445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of media and antifoam selection on monoclonal antibody production and quality using a high throughput micro-bioreactor system.
    Velugula-Yellela SR; Williams A; Trunfio N; Hsu CJ; Chavez B; Yoon S; Agarabi C
    Biotechnol Prog; 2018 Jan; 34(1):262-270. PubMed ID: 29086492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Media supplementation for targeted manipulation of monoclonal antibody galactosylation and fucosylation.
    Wells E; Song L; Greer M; Luo Y; Kurian V; Ogunnaike B; Robinson AS
    Biotechnol Bioeng; 2020 Nov; 117(11):3310-3321. PubMed ID: 32662879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mass spectrometry and HPLC for carbohydrate analysis.
    Siemiiatkoski J; Lyubarskaya Y
    Dev Biol (Basel); 2005; 122():69-74. PubMed ID: 16375251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CHO cell line specific prediction and control of recombinant monoclonal antibody N-glycosylation.
    Grainger RK; James DC
    Biotechnol Bioeng; 2013 Nov; 110(11):2970-83. PubMed ID: 23737295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An ICP-MS platform for metal content assessment of cell culture media and evaluation of spikes in metal concentration on the quality of an IgG3:κ monoclonal antibody during production.
    Mohammad A; Agarabi C; Rogstad S; DiCioccio E; Brorson K; Ashraf M; Faustino PJ; Madhavarao CN
    J Pharm Biomed Anal; 2019 Jan; 162():91-100. PubMed ID: 30227357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.